Bio-Connect

Anti-IGFBP10 [093G9], Human IgG1, Fc Silent(tm), kappa

AB04655-10.3-BT
Absolute Antibody
ApplicationsImmunoFluorescence, Western Blot, ELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityHuman
TargetCCN1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Absolute Antibody
  • Product Name
    Anti-IGFBP10 [093G9], Human IgG1, Fc Silent(tm), kappa
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody binds an epitope comprising amino acids 77 to 80, which lie in the C-terminus of the IGFBP domain of CCN1 (Cyr61). A cyclic peptide encompassing residues 75 to 81 of CCN1 displays high binding affinity for 093G9 (PMID: 28608634). CYR61 is a
  • Application Supplier Note
    This antibody can bind recombinant human Cyr61 (hCyr61) in an indirect ELISA. In a Biacore assay the binding affinity of this antibody for human Cyr61 was assessed. The dissociation constant for the original mouse IgG1 version was reported to be Kd=6.2nM. This antibody could also bind human Cyr61 extracted from MDA-MB-231 cells and rhCyr61 in a western blot. It can also be used to detect natural Cyr61 protein in cells using immunofluorescence assay. This antibody further revealed inhibitory effects on MDA-MB-231 cell proliferation, migration, and invasion through downregulation of both AKT and ERK phosphorylation in vitro. It also showed significant efficacy on suppressing primary tumor growth and spontaneous lymph node metastasis in in vivo mouse model (PMID: 22048717). Blocking of Cyr61 using this antibody in Sjogrens syndrome(SS)-like model mice could partially alleviate the inflammation and structure disruption of the SMG in this disease, indicating Cyr61 indeed aggravates inflammatory reaction in vivo. Blocking Cyr61 also improved saliva secretion by ameliorating inflammatory infiltration and cytokines production in vivo (PMID: 26630293). It was reported that blocking of CCN1 (Cyr61) resulted in substantial decrease in IL-1b production by keratinocytes in 093G9-treated cells (PMID: 28266627). This antibody could also block the effect of Cyr61 on IL-8 production by fibroblast-like synoviocytes (FLS) of rheumatoid arthritis patients (PMID: 24517278).
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, Neutralisation/Blocking, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    093G9
  • Gene ID3491
  • Target name
    CCN1
  • Target description
    cellular communication network factor 1
  • Target synonyms
    CCN family member 1; CYR61; cysteine rich angiogenic inducer 61; cysteine-rich heparin-binding protein 61; cysteine-rich, anigogenic inducer, 61; GIG1; IBP-10; IGF-binding protein 10; IGFBP10; IGFBP-10; insulin-like growth factor-binding protein 10; protein CYR61
  • Host
    Human
  • Isotype
    IgG1
  • Protein IDO00622
  • Protein Name
    Protein CYR61
  • Scientific Description
    This is a reformatted human IgG1 Fc Silent™ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
  • Reactivity
    Human
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203